Upjohn deliberately suppressed knowledge, says QCBMJ 1994; 308 doi: http://dx.doi.org/10.1136/bmj.308.6924.292 (Published 29 January 1994) Cite this as: BMJ 1994;308:292
- c Dyer
The American pharmaceutical company Upjohn knew almost 20 years ago that its sleeping pill Halcion (triazolam) might not be safe but “deliberately suppressed” the knowledge, a QC claimed in the High Court last week. During the years of secrecy Halcion - now banned in Britain - became the world's best selling sleeping pill, with worldwide sales of £237m ($355.5m) in 1991, said Geoffrey Shaw QC. “In short, they got away with it.” Mr Shaw was making a preliminary speech outlining Professor Ian Oswald's defence to a libel claim by Upjohn, its British subsidiary, and its head of European Union affairs, Dr Roy …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial